144 related articles for article (PubMed ID: 9316218)
1. Cost analysis of autologous blood transfusion, using cell salvage, compared with allogeneic blood transfusion.
Duffy G; Tolley K
Transfus Med; 1997 Sep; 7(3):189-96. PubMed ID: 9316218
[TBL] [Abstract][Full Text] [Related]
2. Blood salvage produces higher total blood product costs in single-level lumbar spine surgery.
Canan CE; Myers JA; Owens RK; Crawford CH; Djurasovic M; Burke LO; Bratcher KR; McCarthy KJ; Carreon LY
Spine (Phila Pa 1976); 2013 Apr; 38(8):703-8. PubMed ID: 23044618
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion.
Sonnenberg FA; Gregory P; Yomtovian R; Russell LB; Tierney W; Kosmin M; Carson JL
Transfusion; 1999 Aug; 39(8):808-17. PubMed ID: 10504114
[TBL] [Abstract][Full Text] [Related]
4. The cost effectiveness of preoperative autologous blood donations.
Etchason J; Petz L; Keeler E; Calhoun L; Kleinman S; Snider C; Fink A; Brook R
N Engl J Med; 1995 Mar; 332(11):719-24. PubMed ID: 7854380
[TBL] [Abstract][Full Text] [Related]
5. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of intraoperative blood salvage during orthotopic liver transplantation.
Kemper RR; Menitove JE; Hanto DW
Liver Transpl Surg; 1997 Sep; 3(5):513-7. PubMed ID: 9346794
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of a randomized clinical trial of haemodilution with cell salvage in aortic surgery.
Haynes SL; Torella F; Wong JC; Dalrymple K; James M; McCollum CN
Br J Surg; 2002 Jun; 89(6):731-6. PubMed ID: 12027982
[TBL] [Abstract][Full Text] [Related]
8. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery.
Blumberg N; Kirkley SA; Heal JM
Am J Surg; 1996 Mar; 171(3):324-30. PubMed ID: 8615466
[TBL] [Abstract][Full Text] [Related]
9. The role of intraoperative cell salvage system on blood management in major orthopedic surgeries: a cost-benefit analysis.
Duramaz A; Bilgili MG; Bayram B; Ziroğlu N; Edipoğlu E; Öneş HN; Kural C; Avkan MC
Eur J Orthop Surg Traumatol; 2018 Jul; 28(5):991-997. PubMed ID: 29214459
[TBL] [Abstract][Full Text] [Related]
10. Autologous blood transfusion after primary unilateral total knee replacement surgery.
Dramis A; Plewes J
Acta Orthop Belg; 2006 Jan; 72(1):15-7. PubMed ID: 16570888
[TBL] [Abstract][Full Text] [Related]
11. The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery.
Elmalky M; Yasin N; Rodrigues-Pinto R; Stephenson J; Carroll C; Smurthwaite G; Verma R; Mohammad S; Siddique I
Spine J; 2017 Jul; 17(7):977-982. PubMed ID: 28323241
[TBL] [Abstract][Full Text] [Related]
12. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.
Tretiak R; Laupacis A; Rivière M; McKerracher K; Souêtre E
CMAJ; 1996 May; 154(10):1501-8. PubMed ID: 8625000
[TBL] [Abstract][Full Text] [Related]
13. Relative cost of autologous red cell salvage versus allogeneic red cell transfusion during abdominal aortic aneurysm repair.
Gardner A; Gibbs N; Evans C; Bell R
Anaesth Intensive Care; 2000 Dec; 28(6):646-9. PubMed ID: 11153290
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of cell salvage in pediatric surgery.
Samnaliev M; Tran CM; Sloan SR; Gasior I; Lightdale JR; Brustowicz RM
Paediatr Anaesth; 2013 Nov; 23(11):1027-34. PubMed ID: 23952976
[TBL] [Abstract][Full Text] [Related]
15. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
Glenngård AH; Persson U; Söderman C
Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
[TBL] [Abstract][Full Text] [Related]
16. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
[TBL] [Abstract][Full Text] [Related]
17. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.
Healy JC; Frankforter SA; Graves BK; Reddy RL; Beck JR
Arch Pathol Lab Med; 1994 Apr; 118(4):465-70. PubMed ID: 8166599
[TBL] [Abstract][Full Text] [Related]
18. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
19. Autologous blood salvage in the era of patient blood management.
Sikorski RA; Rizkalla NA; Yang WW; Frank SM
Vox Sang; 2017 Aug; 112(6):499-510. PubMed ID: 28580663
[TBL] [Abstract][Full Text] [Related]
20. Autologous blood transfusion--a review.
Adias TC; Jeremiah Z; Uko E; Osaro E
S Afr J Surg; 2006 Aug; 44(3):114-6, 118. PubMed ID: 16958237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
